PWMG
BIO icon

Private Wealth Management Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Private Wealth Management Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.46K Hold
22
– – ﹤0.01% 738
2026
Q1 		$6.13K Hold
22
– – ﹤0.01% 693
2025
Q4 		$6.67K Sell
22
-1
-4% -$312 ﹤0.01% 663
2025
Q3 		$6.45K Sell
23
-3
-12% -$816 ﹤0.01% 691
2025
Q2 		$6.28K Buy
26
+18
+225% +$4.25K ﹤0.01% 660
2025
Q1 		$1.95K Sell
8
-23
-74% -$6.92K ﹤0.01% 1062
2024
Q4 		$10.2K Hold
31
– – ﹤0.01% 464
2024
Q3 		$10.4K Hold
31
– – ﹤0.01% 447
2024
Q2 		$8.47K Buy
31
+18
+138% +$5.24K ﹤0.01% 492
2024
Q1 		$4.5K Buy
13
+3
+30% +$987 ﹤0.01% 653
2023
Q4 		$3.23K Buy
+10
New +$3.13K ﹤0.01% 773

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Private Wealth Management Group's BIO Position: Q2 2026 in Review

Private Wealth Management Group held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 22 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #738.

Private Wealth Management Group first reported a position in BIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.4K in Q3 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Private Wealth Management Group held 22 shares of Bio-Rad Laboratories Class A worth $6.46K as of Q2 2026.
  • Private Wealth Management Group left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #738 holding.
  • Private Wealth Management Group first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 11 quarters since.
  • Private Wealth Management Group's Bio-Rad Laboratories Class A position peaked at $10.4K in Q3 2024.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.